Milestone moment as AdPha celebrates 500th Resident Training Program graduate
Latrobe Regional Health pharmacist Yue Kee Wong ANZCAP-Res becomes the 500th graduate of AdPha’s nationally recognised Resident Training Program.
Landmark JPPR issue highlights medication safety in 60th year
Special issue of the Journal of Pharmacy Practice and Research spotlights medication safety, introduces AdPha’s Medication Safety Standards, and celebrates 60 years of advancing pharmacy practice in Australia.
MedsAware 2026: Tackling misinformation to support safer medicines use
The fourth annual MedsAware campaign launches today highlighting the importance of trusted advice when making decisions about medicines.
AdPha announces new strategic partnership with Therapeutic Guidelines
Therapeutic Guidelines and Advanced Pharmacy Australia announce a strategic partnership to deliver accessible clinical resources to Australian healthcare professionals. The partnership welcomes the launch of ObesiD, a new digital resource, and the upcoming launch of a redesigned and improved Don’t Rush to Crush.
Call for Abstracts open for landmark 50th Medicines Management conference
Call for Abstracts open until Tuesday 9 June for 50th Medicines Management (MM2026) taking place in Brisbane 22-24 October.
Clinicians call for national advisory line to manage medicines shortages
AdPha urges the Federal Government to establish a national clinical advisory service to help frontline clinicians safely manage medicine shortages, which they say are placing growing pressure on Australia’s health system and patient care.
AdPha highlights medicines shortages at Parliament House summit
AdPha President Assoc. Prof. Tom Simpson FANZCAP (Lead&Mgmt) presented a healthcare perspective on medicine shortages at the GBMA Summit: No Patient Left Waiting, Ending the Era of Medicine Shortages held today at Parliament House in Canberra.
Enhancing Equity of Access and Funding Innovation in MS Care final report
New funding models, workforce reform and decentralised care could transform MS treatment in Australia, according to 11 recommendations released in AdPha’s Enhancing Equity of Access and Funding Innovation in MS Care.